More than 1,000 experts from 65 countries have discussed the present and future of reproductive medicine from 15 to 19 November The use of non-invasive testing has many advantages, making…
9th International IVIRMA Congress, present and future of Reproductive Medicine Ovarian reactivation is emerging as a promising option for patients with a diminished ovarian reserve and poor prognosis, who are…
Within the framework of the 77th Congress of the American Society for Reproductive Medicine (ASRM) Preimplantation genetic testing and the specialisation of the embryologist provide safety and confidence for the…
IVIRMA ) innovation is one of the four pillars of IVIRMA Global, the world’s largest company exclusively devoted to human Assisted Reproduction Technology (ART). A reality that began to take shape in 2017, IVIRMA ) innovation strives to lead scientific research and technology development in reproductive medicine and ART, with the ultimate aim of improving patient care.
To redefine the present and shape the future, IVIRMA brings together innovative investigators from the Old and the New Continent, promotes refining research techniques and encourages sharing knowledge.
Scientific innovation, technological progress, educational commitment, and clinical expertise… with one common goal: Excellence in Patient Care.
